Press release
Dexcom ONE real-time Continuous Glucose Monitoring (rt-CGM) System available on prescription in the UK, improving access to rt-CGM for people with diabetes
The simple and easy to use Dexcom ONE rt-CGM system is now listed on the NHS England, Wales, Scotland and Northern Ireland drug tariffs The first of Dexcom's
About this update from Dexcom, Inc.
[{"type":"text","content":"\n\nThe simple and easy to use Dexcom ONE rt-CGM system is now listed on the NHS England, Wales, Scotland and Northern Ireland drug tariffs\n\n\n\nThe first of Dexcom's scan-free and finger prick-free† devices available on prescription for people with Type 1 diabetes and Type 2 insulin dependent diabetes\n\n\n LONDON--(BUSINESS WIRE)--\nDexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, and NHS England today announced the availability of the easy to use Dexcom ONE rt-CGM System on prescription via the NHS England, Wales, Scotland and Northern Ireland drug tariff to everyone with type 1 or type 2 diabetes using insulin. This marks the first time a rt-CGM, with no scanning and no finger pricks†, will be available to people with diabetes at the pharmacy level.\n\nKaren Baxter, Vice President, UK & Ireland, Benelux, France and Spain at Dexcom: “The addition of Dexcom ONE to the NHS England, Wales, Scotland and Northern Ireland drug tariff is enormous progress towards improving choice of diabetes tech, providing an alternative to burdensome finger pricks and scanning. We are incredibly proud of the diabetes community and are working hard to make it easier for them to access the best technology possible to manage their diabetes. As a next step, we will be working closely with healthcare professionals to ensure the diabetes community can benefit as quickly as possible from reimbursement and wider availability of Dexcom CGM.”\n\nAs of 1 August, patients will receive their starter pack – which will include information on the product and usage, a sensor and transmitter – from the hospital or GP surgery once prescribed, after which they can go to the pharmacy for their repeat prescription. This is an incredible step forward following the new guidelines from the National Institute for Care and Excellence (NICE) which recommends adults with type 1 diabetes should be offered a choice of glucose sensor, children should be offered rt-CGM and people with type 2 diabetes using insulin can be considered for rt-CGM as an alternative to their current sensor. Dexcom ONE is part of a range of CGM systems offered by Dexcom for people with diabetes in the UK that also includes the Dexcom G6 and the upcoming Dexcom G7. With the new portfolio of products, Dexcom meets the entire criteria set ...